Carvedilol ER 40 MG capsule 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F9CWC
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $23,064
Award facts
- Contract value 100% obligated
- $23,064.46 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $23,064.46 to AmerIsourBergen Drug Corp for Carvedilol ER 40 mg capsules (30-count units) on January 8, 2026, with an ultimate completion date of January 9, 2026. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The work will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerIsourBergen Drug Corp is a subsidiary of Cencora, Inc. (doing business as AmerIsourBergen), a major pharmaceutical distributor serving federal healthcare systems including military and veteran health programs.
This delivery order operates under AmerIsourBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at up to $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. Carvedilol, a cardiovascular medication commonly used for heart failure and hypertension management, represents a routine pharmaceutical commodity within the company's extensive federal medical supply portfolio, which also includes specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26F9CWC?
SPE2DR26F9CWC was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 8, 2026.
How much is contract SPE2DR26F9CWC worth?
The government has obligated $23,064 on SPE2DR26F9CWC.
Is contract SPE2DR26F9CWC an order under another contract?
Yes. SPE2DR26F9CWC is a delivery order under SPE2DR25D1017, an indefinite delivery contract.
Was contract SPE2DR26F9CWC competed?
The extent of competition for SPE2DR26F9CWC was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award